DICE Therapeutics, Inc.
DICE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$84 | -$49 | -$24 | -$13 |
| Dep. & Amort. | $2 | $1 | $1 | $1 |
| Deferred Tax | $0 | $2 | $0 | $0 |
| Stock-Based Comp. | $13 | $6 | $1 | $1 |
| Change in WC | $3 | $2 | $2 | -$5 |
| Other Non-Cash | $2 | $0 | $0 | $0 |
| Operating Cash Flow | -$64 | -$39 | -$21 | -$16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$139 | -$218 | -$4 | -$40 |
| Inv. Sales/Matur. | $229 | $15 | $22 | $22 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $87 | -$205 | $18 | -$19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $324 | $215 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $322 | $300 | $54 | -$0 |
| Financing Cash Flow | $322 | $300 | $54 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $345 | $56 | $51 | -$36 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $116 | $60 | $9 | $44 |
| End Cash | $462 | $116 | $60 | $9 |
| Free Cash Flow | -$67 | -$40 | -$21 | -$17 |